Antitumor immune response induction

"Antitumor immune response induction" describes the process of stimulating the body’s immune system to recognize and eliminate tumor cells. This process can involve a wide range of biological mechanisms, including activation of cytotoxic T lymphocytes (especially CD8+ T cells), helper T cells (CD4+), natural killer (NK) cells, antigen presentation by dendritic cells, production of interferons (such as IFN-γ), and inhibition of immune checkpoints like PD-1/PD-L1 or CTLA-4[1][2][3][4]. These events are manipulated therapeutically by immunotherapies such as checkpoint inhibitors, cancer vaccines, cytokines, and adoptive cell therapies. However, as a target name, it is not specific to a single molecule, receptor, or protein but rather encompasses a complex pathway and process. This entry should be flagged as **not specific enough to match a canonical molecular target**—it is a therapeutic strategy, not a discrete molecular entity.